Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Endomines Finland Plc’s Annual Report 2022 is published

Endomines Finland Plc – Stock Exchange Release, 28.4.2023, at 16.30 EET Endomines Finland Plc's Annual Report 2022 has been published. The Annual Report includes the Report of the Board of Directors, the Financial Statements for 2022, the Corporate Governance Statement, the Remuneration Report, and the Sustainability Report. The Financial Statement is published in accordance with the European Single Electronic Format (ESEF) reporting requirements as an XHTML file. In line with the ESEF requirements, the primary statements have been labelled with XBRL tags. The XHTML file and its XBRL

Nokian Tyres plc: Managers' transactions – Lindholm

Nokian Tyres plc Managers’ transactions April 28, 2023 at 4:30 p.m. EEST   The Annual General Meeting of Nokian Tyres plc held on April 26, 2023 decided that 60% of the annual fee of the members of the Board of Directors be paid in cash and 40% in Company shares. Pursuant to said decision, shares have been acquired as follows to Veronica Lindholm: ____________________________________________   Person subject to the notification requirement Name: Lindholm, Veronica Position: Member of the Board/Deputy member Issuer: Nokian Renkaat Oyj LEI: 743700YQIO8Y4L4WKR40

Nokian Tyres plc: Managers' transactions – Vauramo

Nokian Tyres plc Managers’ transactions April 28, 2023 at 4:30 p.m. EEST The Annual General Meeting of Nokian Tyres plc held on April 26, 2023 decided that 60% of the annual fee of the members of the Board of Directors be paid in cash and 40% in Company shares. Pursuant to said decision, shares have been acquired as follows to Pekka Vauramo: ____________________________________________   Person subject to the notification requirement Name: Vauramo, Pekka Position: Member of the Board/Deputy member Issuer: Nokian Renkaat Oyj LEI: 743700YQIO8Y4L4WKR40

Nokian Tyres plc: Managers' transactions – Rytsölä

Nokian Tyres plc Managers’ transactions April 28, 2023 at 4:30 p.m. EEST   The Annual General Meeting of Nokian Tyres plc held on April 26, 2023 decided that 60% of the annual fee of the members of the Board of Directors be paid in cash and 40% in Company shares. Pursuant to said decision, shares have been acquired as follows to Reima Rytsölä: ____________________________________________   Person subject to the notification requirement Name: Rytsölä, Reima Position: Member of the Board/Deputy member Issuer: Nokian Renkaat Oyj LEI: 743700YQIO8Y4L4WKR40

Nokian Tyres plc: Managers' transactions – Rietbergen

Nokian Tyres plc Managers’ transactions April 28, 2023 at 4:30 p.m. EEST The Annual General Meeting of Nokian Tyres plc held on April 26, 2023 decided that 60% of the annual fee of the members of the Board of Directors be paid in cash and 40% in Company shares. Pursuant to said decision, shares have been acquired as follows to George Rietbergen:____________________________________________ Person subject to the notification requirement Name: Rietbergen, George Position: Member of the Board/Deputy member Issuer: Nokian Renkaat Oyj LEI: 743700YQIO8Y4L4WKR40

DNB Bank ASA – Acquisition of shares by primary insiders

Oslo, 28 April 2023 Today, 28 April 2023, a total of 237,050 shares in DNB Bank ASA were acquired on behalf of certain leading employees and risk takers. The purchase was executed collectively at an average price per share of NOK 185.5792. The shares were acquired in accordance with the regulation on remuneration in financial institutions etc., which states that at least half of annual variable remuneration shall be awarded as shares and be subject to certain lock-up mechanisms. The employees have been given a compensation for decreased share value resulting from the lock-up at

Klimator’s solutions becomes a part of Mitsubishi Electric Automotive America flagship- and demo concept vehicle 2023

Today, Mitsubishi Electric Automotive America’s (MEAA) flagship and demo concept vehicle is presented, which includes advanced in-cabin new technologies for 2023. One of which is Klimator's road weather forecasting solutions.Over the past year, Klimator has worked closely with MEAA's Filament Labs team to enable the integration of Klimator's road weather solutions into a new proof of concept vehicle. The demo SUV, which is intended to demonstrate the latest technology to automakers around the world, will be shown during private events and at trade shows, with the first being Auto Tech in

Endomines Finland Oyj Auditor’s Report 2022

Endomines Finland Plc – Financial Statements Release, insider information, 28.4.2023, at 16.15. EET.   Endomines Finland Oyj’s auditor has given the the auditor report today on 28th April 2023. Endomines Finland Oyj has operated as the group's parent company since 16 December 2022, after the transfer of the registered office from Sweden to Finland. The 2022 audit report given to the company today contains information that Endomines Finland Oyj's last year's annual general meeting was held late on August 18, 2022 when the company was a subsidiary without operations. According to the

Notice to attend the Annual General Meeting in Scout Gaming Group AB

The shareholders of Scout Gaming Group AB (publ), reg.no. 559119-1316 (the ”Company”), are hereby given notice to attend the Annual General Meeting to be held at 10:00, Tuesday 30 May 2023, at  Stora Gatan 46 in Sigtuna. Registration and entry commence at 09:45.   Right to attend and notice of attendance Shareholders wishing to exercise their voting rights at the general meeting shall:   -          both be registered in the share register maintained by Euroclear Sweden AB (the Swedish Central Securities Depository) as of the record date on Monday, May 22 2023, and -

Navamedic publishes a supplement to the offer document regarding the unconditional cash offer to the shareholders and holders of warrants of series TO 1 in Sensidose Aktiebolag

This announcement is not an offer, whether directly or indirectly, in Australia, Canada, Hong Kong, Japan, New Zealand, Singapore, South Africa or USA, or in any other jurisdiction where such offer pursuant to legislation, restrictions and regulations in such relevant jurisdiction would be prohibited by applicable law. Shareholders and Warrant Holders not resident in Sweden who wish to accept the Offer, the Revised Offer, the Warrant Offer and the Revised Warrant Offer (as defined below) must make inquiries concerning applicable legislation and possible tax consequences. Shareholders and

Correction of press release: Clean Industry Solutions Holding Europe AB presents the Annual Report 2022

The press release published today at 14:08 CET was published by mistake in the wrong Cision category and is therefore distributed again in the correct category.Today, Clean Industry Solutions Holding Europe AB presents the Annual Report 2022. The report can be found on the company's website: https://cleanindustrysolutions.com/en/investor-relations/financial-reports/

Minutes of Extraordinary General Meeting in Audientes A/S

Company Announcement no.13-2023: On 28th April 2023, at 2 PM (14:00 CET) an extraordinary general meeting was held in Audientes A/S (CVR-no. 36 04 76 31) at the Company’s registered address at: Teknikerbyen 5, 2., 2830 Virum, Denmark. The following items were on the agenda: 1: Election of Chairman of the meeting. 2. Proposal to change the Articles of Association 3. Authorization to inform the Danish Business Authority of decisions taken at the Extraordinary     General Meeting. 4. Any other business. Re 1: Election of Chairman of the meeting The Company’s Chairman of

Report from Annual General Meeting 2023 of Embellence Group AB (publ)

Embellence Group AB (publ) held its Annual General Meeting today, Friday 28 April 2023, at the company’s premises at Ryssnäsgatan 8 in Borås. Attorney Eric Ehrencrona from MAQS Advokatbyrå was elected as chairman of the Annual General Meeting.The following main resolutions were resolved upon at the Annual General Meeting: Adoption of the income statement and balance sheet, and allocation of resultThe Annual General Meeting resolved to adopt the income statement and the balance sheet for the company and the group for the financial year 2022 presented to the Annual General Meeting.

BERGENBIO ASA: Notice of Annual General Meeting

Bergen, Norway – 28 April 2023: BerGenBio ASA (OSE:BGBIO) will be holding its Annual General Meeting virtually on 22 May 2022 at 16:00 hours (CEST).   The notice, registration form, power of attorney and proposal from Nomination Committee are attached to this release. The notice will be sent to all registered shareholders and is available on the Company’s website: https://www.bergenbio.com/investors/general-meetings/   All shareholders are encouraged to exercise their shareholder rights, either through advance electronically voting through VPS Investor Services, by using the

Correction to 2022 financial statement release

Endomines Finland Plc – Financial Statement Release, 28.4.2023, at 16.00 EET.     In connection with the Group's audited Financial Statements, the company revises the figures in the Group's Consolidated Income Statement and Balance Sheet, published in the FY 2022 Financial Statements Release on 15 February 2023.   The corrections have no effect on the turnover, operational costs, or EBITDA of the financial year 2022. Corrections have no cash flow effect.   +-------------------------------------------------+----------------------------------------------------+----------+

Notice of AGM

EnQuest PLC, 28 April 2023 EnQuest PLC Annual Report and Accounts and Notice of Meeting Following the release of EnQuest's 2022 full year audited results on 5 April 2023 and the publication of the Company's 2022 Annual Report and Accounts ('ARA') on 25 April 2023, the Company is pleased to announce that the 2022 ARA and the Notice of the 2023 Annual General Meeting ('AGM') have today been posted to shareholders. These documents are publicly available on the EnQuest PLC website (www.enquest.com), under the Investors section. In compliance with 9.6.1 of the Listing Rules, the Company

Nordic Mining ASA: New share capital registered

Reference is made to the stock exchange release on 17 April 2023 regarding the issuance of 136,544,091 shares in Nordic Mining ASA (the "Company") under the Subsequent Offering. The new share capital following completion of the Subsequent Offering has today been registered with the Norwegian Register of Business Enterprises. The Company's new share capital is NOK 1,300,938,393.0 divided into 2,168,230,655 shares, each with a par value of NOK 0.60. Oslo, 28 April 2023Nordic Mining ASA Nordic Mining ASA (www.nordicmining.com) Nordic Mining ASA (“Nordic Mining” or the “Company”

Swedavia is developing Cargo City at Arlanda - a new center for air cargo and logistics

Stockholm Arlanda Airport is currently in a development phase. Cargo City, a new centre for air cargo, logistics and manufacturing, is being developed in an area close to the terminals, with land for development there covering a total of 144,400 m[2]. Swedavia is looking for one or more partners for a long-term joint venture. Construction is in full swing at Stockholm Arlanda Airport. In the summer of 2023, a new security checkpoint will open in Terminal 5, and in the autumn the first step of new Marketplace will open – the largest commercial investment ever at Arlanda. But

BioStock article: Aptahem on the need for more effective sepsis treatments

Biotechnology company Aptahem is developing Apta-1, a drug candidate whose purpose is to reduce the high mortality and severe tissue damage that can occur in sepsis. BioStock contacted Luiza Jedlina, Chief Scientific Officer and co-founder of Aptahem, to talk about the need for better treatment options than antibiotics.Read the full interview with Luiza Jedlina at biostock.se: https://www.biostock.se/en/2023/04/aptahem-on-the-need-for-more-effective-sepsis-treatments/ For further information: Aptahem ABMikael Lindstam, CEOTel: +46 (0)766-33 36 99E-mail: ml@aptahem.com

DexTech Medical AB Interim report July 1, 2022 - March 31, 2023

Summary of the third quarter (2023-01-01 – 2023-03-31) · Patient recruitment has begun for the Multiple Myeloma study · Net sales amounted to MSEK 0,0 (0,0) · Operating profit/loss amounted to MSEK -1,6 (-1,1) · Earnings per share* SEK -0.08 (-0.06) * Before and after dilution. Earnings per share: Profit for the period divided by the average number of shares 18,485,857. For the comparison period, the average number of shares was 18,485,857. Amounts in brackets refer to the corresponding period last year. Summary of the nine-month period (2022-07-01 – 2023-03-31) ·

Change in the number of shares and votes in Starbreeze AB

In accordance with Starbreeze’ articles of association, holders of series A-shares have the right to request that the shares be converted into series B-shares. Such a conversion reduces the total number of votes in the company. When such conversion has taken place, the company has an obligation according to law to publish information about any changes on a monthly basis.During the current month, at the request of shareholder’s, 552,195 shares of series A-shares have been converted into the same number of series B-shares. The total number of votes in Starbreeze then amounts to 2,203,386,648.

Arranta Bio, a Recipharm company, signs contract with MIT to develop rapid manufacturing of mRNA therapeutics

· Contract with MIT follows the largest award from FDA’s Center for Biologics Evaluation and Research office (CBER) to MIT · Potential to support better response to new pandemic threatsArranta Bio, part of Recipharm’s biologics business, has signed a contract with MIT to develop a continuous manufacturing technology for mRNA therapeutics. The contract is part of the FDA’s initiative to have a fully integrated, continuous manufacturing production line for mRNA vaccines, which the agency is funding through a contract to MIT – one of the largest awards from the FDA’s CBER office. Enabling

BioStock: Aptahem on the need for more effective sepsis treatments

Biotechnology company Aptahem is developing Apta-1, a drug candidate whose purpose is to reduce the high mortality and severe tissue damage that can occur in sepsis. BioStock contacted Luiza Jedlina, Chief Scientific Officer and co-founder of Aptahem, to talk about the need for better treatment options than antibiotics.Read the full interview with Luiza Jedlina at biostock.se: https://www.biostock.se/en/2023/04/aptahem-on-the-need-for-more-effective-sepsis-treatments/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

There are no items matching the current filter
There are no more items matching the current filter
Back to top